NuVasive Competitors

Applied Medical is dedicated to providing innovative products that improve patient outcomes and enable the advancement of minimally invasive surgery. As a new generation medical device company, we are equally committed to improving the affordability and accessibility of high-quality healthcare. In order to fulfill this commitment, we invest heavily in vertical integration, R&D, advanced manufacturing technologies, and most importantly–the growth of our team members. Applied Medical is a rapidly growing, global organisation with over 60 team members based in Australia, 3500 team members world wide. We are proud to provide our products and unique business model to more than 75 countries. Each year, we devote, on average, 20% of our revenue to R&D – a significantly higher percentage than our competitors. As a result, we have a portfolio of clinically advanced products and a pipeline filled with the next generation of enabling technologies for minimally invasive surgery. Currently, we offer breakthrough technologies in the following product categories: • Abdominal access • Hand access laparoscopy • Single site laparoscopy • Transanal access • Laparoscopic instrumentation • Wound protection/retraction • Endourological stone management • Vascular/cardiovascular occlusion and clot management

Globus Medical, Inc. is a leading musculoskeletal solutions company and is driving significant technological advancements across a complete suite of products. Founded in 2003, Globus’ single-minded focus on advancing surgery has made it the fastest growing company in the history of orthopedics. Globus is driven to utilize superior engineering and technology to achieve pain free, active lives for all patients. Additional information can be accessed at www.globusmedical.com. IMPORTANT NOTICE TO JOB APPLICANTS: POTENTIAL FRAUD ALERT. Globus Medical has been made aware of an online scam where unknown entities are posing as Globus Medical recruiters in an attempt to obtain personal information as part of our application or job offer process. Before providing any personal information to outside parties, please verify the following: • All legitimate Globus Medical recruiter email addresses end with “@globusmedical.com” • No application process should include a cloud-based document (ex. Google doc) asking for personal information • The position described is found on our careers site at globusmedical.com/careers

Biosensors International develops, manufactures and markets pioneering interventional cardiology devices. The BioMatrix™ DES family features Biolimus A9™ (BA9™), a highly lipophilic anti-restenotic drug designed for cardiovascular stent technologies patented by Biosensors, combined in a unique abluminal biodegradable polymer coating. BioMatrix Alpha™, the latest addition to the family, is a CoCr stent featuring an innovative hybrid design, thin struts and an advanced delivery system. BioFreedom™ demonstrated superior safety and efficacy vs BMS in High Bleeding Risk patients in the landmark LEADERS FREE trial and features a selectively micro-structured abluminal surface allowing polymer & carrier free delivery of BA9™. Recently Biosensors’ parent company made a significant investment into the rapidly growing field of structural heart disease intervention through the acquisition of the company New Valve Technology (NVT), the developers of the flagship product Allegra™ transfemoral TAVI system. Together, Biosensors and NVT will leverage our their respective innovative expertise in Cardiovascular and Structural Heart technologies. Our aim is to improve patients’ lives through pioneering medical technology that pushes the boundaries of innovation. Through our high quality medical devices we impact the lives we touch and we are committed to continued investment in the development of pioneering medical technology, robust clinical data and engineering new medical devices that will further benefit your patients.